NCT05920434

Brief Summary

Introduction: Pain relief in diabetic neuropathy is one of the main goals of treatment. Foot reflexology and foot bath, which are two of the important applications of holistic approaches, reduce pain and can significantly increase the quality of life. Objective: In the current study, it was aimed to examine the effects of foot reflexology and foot bath applied to diabetic individuals with neuropathic pain on pain and quality of life. Method: In this randomized controlled study, the sample was randomized into three groups: (I) Foot reflexology (n: 30), (II) Foot bath (n: 30), and (III) Control (n: 30). The "Patient Information Form", "DN4 Pain Questionnaire", "Neuropathic Pain Impact on Quality-of-Life questionnaire (NePIQoL)", and "Visual Analog Scale (VAS)" were used to collect research data. In the study, a protective sensory examination was also performed with the Semmes-Weinstein Monofilament (SWM) Test and the Vibration Test (128 Hz diapason). Apart from these, foot care training was given to all patients included in the practice groups as the role of the diabetes nurse, based on the diabetic foot care training prepared by the Turkish Diabetes Association.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 19, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 21, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2021

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

February 1, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

June 27, 2023

Completed
Last Updated

June 27, 2023

Status Verified

June 1, 2023

Enrollment Period

1 month

First QC Date

February 1, 2023

Last Update Submit

June 17, 2023

Conditions

Keywords

DiabetesNeuropathic PainFoot ReflexologyFoot Bath

Outcome Measures

Primary Outcomes (2)

  • Pain scores

    Douleur Neuropathique 4 Questions -It consists of 10 questions in total. The total scale score is calculated by giving 1 point for the yes answer given by the patient to each of the questions and examination findings, and 0 points for the no answer. The lowest score is 0, the highest 10 points can be obtained. is evaluated.

    6 weeks

  • Pain severity

    Visual Analog Scale (VAS)-It is an equidistant scale on a 10 cm horizontal plane, on one side of which there is no pain and on the other side the pain is "unbearable". The patient is asked to mark the point on this line that best expresses the severity of his or her pain. This distance, measured in millimeters, is interpreted as a "score" .For pain severity, 0 points are "no pain" and 10 points are "worst unbearable pain". evaluated as.

    6 weeks

Secondary Outcomes (2)

  • Sensory level

    6 weeks

  • Vibration sense

    6 weeks

Other Outcomes (1)

  • The quality of life

    6 weeks

Study Arms (3)

Foot reflexology group

EXPERIMENTAL

Individuals in the foot reflexology group were treated by the researcher once a week for a total of 60 minutes, 30 minutes on each foot, for 6 weeks (28,29) (Figure 2C).

Other: randomized controlled study

Foot bath group

EXPERIMENTAL

In the first meeting, each participant in the foot bath group was informed about the way of doing a footbath in practice. Each participant in the foot bath group was asked to apply a foot bath for 10 minutes, 3 times a week, and twice a day for 6 weeks. A plastic foot bath tub (42 x 37 x 12 cm) without a massage function is provided for each of the participant s (Figure 2D). In order not to miss the applications, the participant was followed up by phone on the specified days (3 times a week, Monday-Wednesday-Friday). Th participant was told that the foot bath water should be at 40 degrees celsius and that his feet should be kept in water for 10 minutes, approximately 10 cm above the ankle (24). The participant came to the clinic for the forms and protective sensory examination in the 2nd, 4th, and last week.

Other: randomized controlled study

Control group

NO INTERVENTION

Forms and protective sensory examination tests were applied to the participant s in the control group, as in the intervention groups, and no application was made other than standard nursing care.

Interventions

randomized controlled study,no drugs or devices were administered to the participants.

Foot bath groupFoot reflexology group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants diagnosed with diabetes and the value of HgbA1c ≥ 6.5,
  • Participants with the DN4 ≥ 4,
  • Participants with the VAS ≥ 4.

You may not qualify if:

  • Participants who were pregnant
  • Participants who received any other complementary therapy during the period of the study,
  • Participants who had history of systolic blood pressure lower than 100 mmHg in the past,
  • Participants who were taking systemic corticosteroids in the previous month,
  • Participants who with peripheral artery disease, gonarthrosis, spinal disc herniation, ankle tendonitis, active foot ulcer, and infection
  • Participants who had histories of Kidney, heart and brain diseases, rheumatic diseases, thyroid diseases, other hormonal disorders, and malignancy,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reva Gundogan

Adıyaman, 02100, Turkey (Türkiye)

Location

Related Publications (1)

  • Zakin E, Abrams R, Simpson DM. Diabetic Neuropathy. Semin Neurol. 2019 Oct;39(5):560-569. doi: 10.1055/s-0039-1688978. Epub 2019 Oct 22.

    PMID: 31639839BACKGROUND

Related Links

MeSH Terms

Conditions

Diabetic NeuropathiesDiabetes MellitusNeuralgia

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesDiabetes ComplicationsEndocrine System DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Reva Gundogan, Expert Nurse

    Adıyaman Provincial Health Directorate, Adıyaman Provincial Ambulance Chief Physician

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Expert Nurse

Study Record Dates

First Submitted

February 1, 2023

First Posted

June 27, 2023

Study Start

July 19, 2020

Primary Completion

August 21, 2020

Study Completion

March 22, 2021

Last Updated

June 27, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

IPD will be stored by researchers.

Locations